- Home
- HTO vs RXRX Comparison
HTO vs RXRX Comparison
Compare HTO & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HTO | RXRX |
|---|---|---|
| Founded | 1985 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HTO | RXRX |
|---|---|---|
| Price | $60.99 | $3.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $67.13 | $7.32 |
| AVG Volume (30 Days) | 903.1K | ★ 20.9M |
| Earning Date | 10-26-2026 | 11-02-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | 1.74 | ★ 14.79 |
| EPS | ★ 2.13 | N/A |
| Revenue | ★ $800,590,000.00 | $74,681,000.00 |
| Revenue This Year | $7.69 | N/A |
| Revenue Next Year | $6.98 | $49.16 |
| P/E Ratio | $28.77 | ★ N/A |
| Revenue Growth | 6.97 | ★ 26.92 |
| 52 Week Low | $43.75 | $2.77 |
| 52 Week High | $67.09 | $5.24 |
Technical Indicators
Market Signals| Indicator | HTO | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.83 | 42.44 |
| Support Level | $55.75 | $2.90 |
| Resistance Level | $62.57 | $3.66 |
| Average True Range (ATR) | 1.74 | 0.32 |
| MACD | 0.22 | -0.05 |
| Stochastic Oscillator | 56.11 | 9.60 |
Price Performance
Historical ComparisonAbout HTO H2O America
H2O America is a national investor-owned network of local water and wastewater utilities united by one purpose: delivering clean, high-quality water to the communities it calls home. Across approximately 407,000 water and wastewater service connections, the company invests in critical infrastructure to strengthen the water supply for generations to come. Its single reportable segment provides water utility and utility-related services to its customers.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.